94 related articles for article (PubMed ID: 22195852)
21. In vitro characterization and invivo toxicity study of repaglinide loaded poly (methyl methacrylate) nanoparticles.
Dhana Lekshmi UM; Poovi G; Kishore N; Reddy PN
Int J Pharm; 2010 Aug; 396(1-2):194-203. PubMed ID: 20600729
[TBL] [Abstract][Full Text] [Related]
22. Effect of mean diameter and polydispersity of PLG microspheres on drug release: experiment and theory.
Berchane NS; Carson KH; Rice-Ficht AC; Andrews MJ
Int J Pharm; 2007 Jun; 337(1-2):118-26. PubMed ID: 17289316
[TBL] [Abstract][Full Text] [Related]
23. Controlled heparin release from electrospun gelatin fibers.
Wang H; Feng Y; Zhao H; Lu J; Guo J; Behl M; Lendlein A
J Control Release; 2011 Nov; 152 Suppl 1():e28-9. PubMed ID: 22195905
[No Abstract] [Full Text] [Related]
24. In situ forming implant for controlled delivery of an anti-HIV fusion inhibitor.
Kapoor DN; Katare OP; Dhawan S
Int J Pharm; 2012 Apr; 426(1-2):132-143. PubMed ID: 22266533
[TBL] [Abstract][Full Text] [Related]
25. Effect of acidic pH on PLGA microsphere degradation and release.
Zolnik BS; Burgess DJ
J Control Release; 2007 Oct; 122(3):338-44. PubMed ID: 17644208
[TBL] [Abstract][Full Text] [Related]
26. Thermal behavior and stability of biodegradable spray-dried microparticles containing triamcinolone.
da Silva AA; de Matos JR; Formariz TP; Rossanezi G; Scarpa MV; do Egito ES; de Oliveira AG
Int J Pharm; 2009 Feb; 368(1-2):45-55. PubMed ID: 18992313
[TBL] [Abstract][Full Text] [Related]
27. A facile way to fabricate polyester microcapsules.
Yu X; Zhu J
J Control Release; 2011 Nov; 152 Suppl 1():e128-9. PubMed ID: 22195798
[No Abstract] [Full Text] [Related]
28. Preparation and in vitro release of spray-dried chitosan microspheres for levofloxacin delivery.
Cai J; Zhang Y; Du W; Nan K
J Control Release; 2011 Nov; 152 Suppl 1():e70-1. PubMed ID: 22195935
[No Abstract] [Full Text] [Related]
29. Supramolecular organization and release properties of phospholipid-hyaluronan microparticles encapsulating dexamethasone.
Gómez-Gaete C; Tsapis N; Silva L; Bourgaux C; Besnard M; Bochot A; Fattal E
Eur J Pharm Biopharm; 2008 Sep; 70(1):116-26. PubMed ID: 18585906
[TBL] [Abstract][Full Text] [Related]
30. Design and optimization of NSAID loaded nanoparticles.
Sashmal S; Mukherjee S; Ray S; Thakur RS; Ghosh LK; Gupta BK
Pak J Pharm Sci; 2007 Apr; 20(2):157-62. PubMed ID: 17416573
[TBL] [Abstract][Full Text] [Related]
31. Preparation and evaluation of injectable sustained-release microspheres of rivastigmine.
Zhu Y; Zhu Z; Cao Q; Chen D; Cui J
J Control Release; 2011 Nov; 152 Suppl 1():e131-2. PubMed ID: 22195801
[No Abstract] [Full Text] [Related]
32. Tailoring the PLATMC chain microstructure for stable cyclosporine A release.
Kasperczyk J; Jelonek K; Gębarowska K; Dobrzyński P; Smola A
J Control Release; 2011 Nov; 152 Suppl 1():e42-4. PubMed ID: 22195915
[No Abstract] [Full Text] [Related]
33. Drug carriers based on cyclodextrin inclusion complexes for the controlled release of hydrophobic drugs.
Xiong L; Zheng L; Han K; Liu Q; Li Y; Liu W; Xia J; Wang W
J Control Release; 2011 Nov; 152 Suppl 1():e121-3. PubMed ID: 22195793
[No Abstract] [Full Text] [Related]
34. Entrapment of andrographolide in cross-linked alginate pellets: II. Physicochemical characterization to study the pelletization of andrographolide.
Shariff A; PK M; KLK P; M M
Pak J Pharm Sci; 2007 Jan; 20(1):9-15. PubMed ID: 17337421
[TBL] [Abstract][Full Text] [Related]
35. Development of disulfiram-loaded poly(lactic-co-glycolic acid) wafers for the localised treatment of glioblastoma multiforme: a comparison of manufacturing techniques.
Zembko I; Ahmed I; Farooq A; Dail J; Tawari P; Wang W; Mcconville C
J Pharm Sci; 2015 Mar; 104(3):1076-86. PubMed ID: 25537972
[TBL] [Abstract][Full Text] [Related]
36. Effects of the type of release medium on drug release from PLGA-based microparticles: experiment and theory.
Faisant N; Akiki J; Siepmann F; Benoit JP; Siepmann J
Int J Pharm; 2006 May; 314(2):189-97. PubMed ID: 16510257
[TBL] [Abstract][Full Text] [Related]
37. Long acting porous microparticle for pulmonary protein delivery.
Kwon MJ; Bae JH; Kim JJ; Na K; Lee ES
Int J Pharm; 2007 Mar; 333(1-2):5-9. PubMed ID: 17296275
[TBL] [Abstract][Full Text] [Related]
38. Thermodynamic phase behaviour of indomethacin/PLGA formulations.
Prudic A; Lesniak AK; Ji Y; Sadowski G
Eur J Pharm Biopharm; 2015 Jun; 93():88-94. PubMed ID: 25791211
[TBL] [Abstract][Full Text] [Related]
39. Ciprofloxacin-encapsulated poly(DL-lactide-co-glycolide) nanoparticles and its antibacterial activity.
Jeong YI; Na HS; Seo DH; Kim DG; Lee HC; Jang MK; Na SK; Roh SH; Kim SI; Nah JW
Int J Pharm; 2008 Mar; 352(1-2):317-23. PubMed ID: 18160236
[TBL] [Abstract][Full Text] [Related]
40. Processing ulvan into 2D structures: cross-linked ulvan membranes as new biomaterials for drug delivery applications.
Alves A; Pinho ED; Neves NM; Sousa RA; Reis RL
Int J Pharm; 2012 Apr; 426(1-2):76-81. PubMed ID: 22281048
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
